Latest Regulatory News

Amplia Therapeutics reports a remarkable 7.8% complete response rate and improved survival in its ACCENT pancreatic cancer trial, positioning narmafotinib as a promising new treatment option.

Sequoia Financial Group has agreed to sell its financial planning arm InterPrac to Conquest Investment Partners for $50,000, following a strategic review that exposed significant challenges and asset write-downs.

Peppermint Innovation Limited reported a $1.27 million net loss for the half-year ending December 2025 while achieving key milestones including activation of national payment rails in the Philippines and settling a statutory demand that led to an ASX trading suspension.

White Cliff Minerals has initiated the restart of drilling operations at its Rae Copper Project in Nunavut, Canada, aiming to expand high-grade sedimentary copper mineralisation along key fault zones.

The Speewah Fluorite Project in Western Australia has been officially recognised by the Japanese and US governments as a critical minerals supply chain asset, signalling strong international support and potential financial backing.

Triangle Energy has secured joint funding with Tetragon and Winchester Energy to undertake a strategic exploration study in Indonesia, potentially paving the way for a new production sharing contract.

Sentinel Metals has reached a pivotal regulatory milestone as its Columbia Gold-Silver Project’s exploration amendment enters the public comment phase, paving the way for maiden drilling expected in April 2026.

Felix Gold has secured a bulk sampling permit to extract 1,600 tons of high-grade antimony ore from its Treasure Creek project in Alaska, marking a pivotal step towards near-term production. The permit supports multiple production pathways, including toll treatment in 2026 and a dedicated smelter by 2027.

Minerals 260 secures Foreign Investment Review Board approval, enabling Franco-Nevada to complete a $220 million funding package that accelerates development of the Bullabulling Gold Project.

Cleo Diagnostics has expanded its ovarian cancer biomarker panel from five to eight markers, enhancing test reliability and gearing up for FDA submission. A manufacturing deal is imminent, setting the stage for commercial rollout.

LCL Resources has secured a transformative farm-in deal with Rio Tinto, which could see the mining giant earn up to an 80% stake in the promising Ono Project through substantial exploration funding and milestone payments.

Nexsen Limited has successfully completed a pivotal FDA Pre-Submission meeting for its StrepSure® diagnostic, significantly reducing regulatory risks and advancing its entry into the large US maternal health market.